Page 19 - அமெரிக்கன் சங்கம் க்கு புற்றுநோய் ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Lung cancer patients should be screened for MET oncogene amplification, research suggests Research by investigators at Mayo Clinic Cancer Center suggests that physicians should screen patients with lung cancer for MET amplification/overexpression before determining a treatment strategy. Their findings are published Cancer Discovery, a journal of the American Association for Cancer Research. In our research we found several lung cancer cases that were not responsive to standard chemotherapy, says Zhenkun Lou, Ph.D., a cancer researcher at Mayo Clinic. Because these lung cancers were positive for PD-L1, a protein that allows some cells to escape attack by the immune system, we then tried treating these patients with anti-PD1 immunotherapy to relieve PD-L1 mediated immune suppression, however this treatment also failed.

United statesZhenkun louEmily hendersonAmerican association for cancer researchMayo clinic cancer centerCancer discoveryAmerican associationஒன்றுபட்டது மாநிலங்களில்எமிலி ஹென்டர்சன்அமெரிக்கன் சங்கம் க்கு புற்றுநோய் ஆராய்ச்சிமயோ சிகிச்சையகம் புற்றுநோய் மையம்புற்றுநோய் கண்டுபிடிப்புஅமெரிக்கன் சங்கம்